or Try an Advanced Search...

    Duchenne Stocks List

    Symbol Grade Name % Change
    SRPT B Sarepta Therapeutics, Inc. 2.32
    SMMT C Summit Therapeutics plc 8.13
    WVE C WAVE Life Sciences Ltd. 4.42
    DYN D Dyne Therapeutics, Inc. 0.31
    TRDA D Entrada Therapeutics, Inc. -2.95
    SLDB D Solid Biosciences Inc. -1.27
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Duchenne Muscular Dystrophy Dystrophy Muscular Dystrophy Disease Dystrophin Genetic Genealogy Medical Genetics Biopharmaceutical Biotechnology Cytoskeleton Medicine Myotonic Dystrophy Rare Diseases Acid Antibiotics Antisense RNA Biology Cdi Clinical Development Clinical Research

    Related ETFs - A few ETFs which own one or more of the above listed Duchenne stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 8.83
    PINK C Simplify Health Care ETF 8.61
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.83
    GNOM D Global X Genomics & Biotechnology ETF 4.4
    BTEC C Principal Healthcare Innovators Index ETF 3.97
    View all Duchenne ETFs...
    Compare ETFs
    Compare IBRN to IDNA Compare IBRN to PINK Compare PINK to IDNA

        Duchenne Stocks Recent News

        Date Stock Title
        May 5 SRPT Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
        May 3 SRPT Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
        May 3 DYN Dyne Therapeutics GAAP EPS of -$0.81 misses by $0.01
        May 2 DYN Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
        May 2 SRPT Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
        May 2 SRPT Sarepta Elevidys accelerated approval criticized by ICER exec
        May 2 SMMT Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
        May 2 SRPT Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
        May 2 SRPT Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
        May 2 WVE Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
        May 2 SRPT Q1 2024 Sarepta Therapeutics Inc Earnings Call
        May 2 SRPT Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
        May 2 SMMT Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
        May 2 SMMT Q1 2024 Summit Therapeutics Inc Earnings Call
        May 2 SMMT Summit Therapeutics Inc. (SMMT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript
        May 1 SRPT Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
        May 1 SRPT Sarepta Therapeutics jumps 5% on Q1 beats
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Duchenne Muscular Dystrophy Dystrophy Muscular Dystrophy Disease Dystrophin Genetic Genealogy Medical Genetics Biopharmaceutical Biotechnology Cytoskeleton Medicine Myotonic Dystrophy Rare Diseases Acid Antibiotics Antisense RNA Biology Cdi Clinical Development Clinical Research
        Duchenne

        Browse All Tags